{"transactions":[{"id":4628146,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-29T20:01:05.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":764871,"source":{"system":"sec-edgar","filing":"0001683168-26-007483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007483/ownership.xml","form_type":"4"}},{"id":4625347,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-23T20:01:23.000Z","date":"2026-09-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.0289,"value":2057.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":364871,"source":{"system":"sec-edgar","filing":"0001683168-26-007321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007321/ownership.xml","form_type":"4"}},{"id":4617771,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-15T20:00:29.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":68550,"price":1.03,"value":70606.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":362871,"source":{"system":"sec-edgar","filing":"0001683168-26-007159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007159/ownership.xml","form_type":"4"}},{"id":681141,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-08-19T20:01:10.000Z","date":"2026-08-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.06,"value":10600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":431421,"source":{"system":"sec-edgar","filing":"0001683168-26-006592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826006592/ownership.xml","form_type":"4"}},{"id":723813,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-06-29T20:02:13.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.99,"value":9900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":421421,"source":{"system":"sec-edgar","filing":"0001683168-26-005164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826005164/ownership.xml","form_type":"4"}},{"id":915851,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T12:56:15.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":411421,"source":{"system":"sec-edgar","filing":"0001683168-26-000803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826000803/ownership.xml","form_type":"4"}},{"id":954997,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-01-02T21:05:06.000Z","date":"2025-12-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.03,"value":5150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":291421,"source":{"system":"sec-edgar","filing":"0001683168-26-000013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826000013/ownership.xml","form_type":"4"}},{"id":958032,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-12-29T13:10:21.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.02,"value":5100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":286421,"source":{"system":"sec-edgar","filing":"0001683168-25-009349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825009349/ownership.xml","form_type":"4"}},{"id":989772,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-11-24T17:54:10.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.14,"value":5700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":281421,"source":{"system":"sec-edgar","filing":"0001683168-25-008639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825008639/ownership.xml","form_type":"4"}},{"id":993580,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-11-19T17:47:40.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.27,"value":6350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":276421,"source":{"system":"sec-edgar","filing":"0001683168-25-008537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825008537/ownership.xml","form_type":"4"}},{"id":1040209,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:28:05.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":271421,"source":{"system":"sec-edgar","filing":"0001683168-25-006954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825006954/ownership.xml","form_type":"4"}},{"id":1040208,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:28:05.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4111,"price":2.32,"value":9537.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."}],"balance_after":21421,"source":{"system":"sec-edgar","filing":"0001683168-25-006954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825006954/ownership.xml","form_type":"4"}},{"id":1114717,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-11T21:00:01.000Z","date":"2025-06-10","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.42,"value":4840.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":27149,"source":{"system":"sec-edgar","filing":"0001062993-25-011424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325011424/form4.xml","form_type":"4"}},{"id":1116110,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-10T20:43:57.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":2.75,"value":4125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25149,"source":{"system":"sec-edgar","filing":"0001062993-25-011326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325011326/form4.xml","form_type":"4"}},{"id":1134939,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-23T13:04:08.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":1200,"price":1.7799,"value":2135.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":23649,"source":{"system":"sec-edgar","filing":"0001062993-25-010155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325010155/form4.xml","form_type":"4"}},{"id":1134938,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-23T13:04:08.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":1.77,"value":5310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":22449,"source":{"system":"sec-edgar","filing":"0001062993-25-010155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325010155/form4.xml","form_type":"4"}},{"id":1407498,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-13T18:59:23.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":17832,"source":{"system":"sec-edgar","filing":"0001683168-24-006373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824006373/ownership.xml","form_type":"4"}},{"id":1483161,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-06-11T21:00:11.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.74,"value":740.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20990,"source":{"system":"sec-edgar","filing":"0001683168-24-004126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824004126/ownership.xml","form_type":"4"}},{"id":1484614,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-06-10T21:00:16.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.75,"value":750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":19990,"source":{"system":"sec-edgar","filing":"0001683168-24-004089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824004089/ownership.xml","form_type":"4"}},{"id":1615137,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-27T21:42:27.000Z","date":"2024-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.91,"value":2275.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18990,"source":{"system":"sec-edgar","filing":"0001683168-24-001216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824001216/ownership.xml","form_type":"4"}},{"id":1624993,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-23T00:00:12.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1804,"price":0.76,"value":1371.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":16490,"source":{"system":"sec-edgar","filing":"0001683168-24-001134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824001134/ownership.xml","form_type":"4"}},{"id":1766815,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-10-03T23:00:14.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":917,"price":1.51,"value":1384.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18294,"source":{"system":"sec-edgar","filing":"0001209191-23-051706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123051706/doc4.xml","form_type":"4"}},{"id":1835452,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-07-05T22:00:29.000Z","date":"2023-07-01","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.84,"value":2840.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":19211,"source":{"system":"sec-edgar","filing":"0001209191-23-041254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123041254/doc4.xml","form_type":"4"}},{"id":1835451,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-07-05T22:00:29.000Z","date":"2023-06-30","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.88,"value":2880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18211,"source":{"system":"sec-edgar","filing":"0001209191-23-041254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123041254/doc4.xml","form_type":"4"}},{"id":1999110,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:00:10.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in two equal annual installments commencing on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":17211,"source":{"system":"sec-edgar","filing":"0001209191-23-011909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123011909/doc4.xml","form_type":"4"}},{"id":2084889,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-15T22:00:30.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":2000,"price":0.39,"value":780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":74541,"source":{"system":"sec-edgar","filing":"0001209191-22-061471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122061471/doc4.xml","form_type":"4"}},{"id":2092051,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-08T21:30:23.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":2000,"price":0.39,"value":780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":72541,"source":{"system":"sec-edgar","filing":"0001209191-22-060358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122060358/doc4.xml","form_type":"4"}},{"id":2094256,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-06T21:30:18.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":2000,"price":0.43,"value":860.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":70541,"source":{"system":"sec-edgar","filing":"0001209191-22-060009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122060009/doc4.xml","form_type":"4"}},{"id":2102273,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-29T21:30:15.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":215,"price":0.4,"value":86.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":68541,"source":{"system":"sec-edgar","filing":"0001209191-22-058942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122058942/doc4.xml","form_type":"4"}},{"id":2102272,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-29T21:30:15.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":2500,"price":0.42,"value":1050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":68326,"source":{"system":"sec-edgar","filing":"0001209191-22-058942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122058942/doc4.xml","form_type":"4"}},{"id":2114304,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Series D Preferred Stock, $0.0001 par value","published_at":"2022-11-16T22:06:34.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":1,"price":1750,"value":1750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The outstanding share of Series D Preferred Stock shall be redeemed in whole, but not in part, at any time: (i) if such redemption is approved by the Board of Directors in its sole discretion or (ii) automatically and effective upon the approval of an amendment to the Certificate of Incorporation to implement a reverse stock split. Upon redemption, the share of Series D Preferred Stock will receive consideration of $1,750.00 in cash."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001209191-22-057333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122057333/doc4.xml","form_type":"4"}},{"id":2147054,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-10-04T00:01:10.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":65826,"source":{"system":"sec-edgar","filing":"0001209191-22-051984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122051984/doc4.xml","form_type":"4"}},{"id":2391452,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T00:59:51.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25826,"source":{"system":"sec-edgar","filing":"0001209191-22-010372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122010372/doc4.xml","form_type":"4"}},{"id":2812165,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:18.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":15826,"source":{"system":"sec-edgar","filing":"0001209191-21-017570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919121017570/doc4.xml","form_type":"4"}},{"id":3363975,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-21T00:38:56.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":300000,"price":0.1,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":320440,"source":{"system":"sec-edgar","filing":"0001209191-19-057518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919119057518/doc4.xml","form_type":"4"}},{"id":3653403,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-02-16T02:05:01.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":20440,"source":{"system":"sec-edgar","filing":"0001209191-19-010824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919119010824/doc4.xml","form_type":"4"}},{"id":3852890,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-04T01:31:55.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":10440,"source":{"system":"sec-edgar","filing":"0001209191-18-045457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919118045457/doc4.xml","form_type":"4"}},{"id":4468089,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-02-03T22:20:10.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date."}],"balance_after":2000,"derivative":{"exercise_price":0.629,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-007732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919117007732/doc4.xml","form_type":"4"}}]}